TY - JOUR
T1 - Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease
AU - Kirino, Yohei
AU - Yasukawa, Takehiro
AU - Ohta, Shigeo
AU - Akira, Shigeo
AU - Ishihara, Kaisuke
AU - Watanabe, Kimitsuna
AU - Suzuki, Tsutomu
PY - 2004/10/19
Y1 - 2004/10/19
N2 - Point mutations in the mitochondrial (mt) tRNALeu(UUR) gene are responsible for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), a subgroup of mitochondrial encephalomyopathic diseases. We previously showed that mt tRNALeu(UUR) with an A3243G or T3271C mutation derived from patients with MELAS are deficient in a normal taurine-containing modification (τm5U; 5-taurinomethyluridine) at the anticodon wobble position. To examine decoding disorder of the mutant tRMA due to the wobble modification deficiency independent of the pathogenic point mutation itself, we used a molecular surgery technique to construct an mt tRNALeu(UUR) molecule lacking the taurine modification but without the pathogenic mutation. This "operated" mt tRNALeu(UUR) without the taurine modification showed severely reduced UUG translation but no decrease in UUA translation. We thus concluded that the UUG codon-specific translational defect of the mutant mt tRNAsLeu(UUR) is the primary cause of MELAS at the molecular level. This result could explain the complex I deficiency observed clinically in MELAS.
AB - Point mutations in the mitochondrial (mt) tRNALeu(UUR) gene are responsible for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), a subgroup of mitochondrial encephalomyopathic diseases. We previously showed that mt tRNALeu(UUR) with an A3243G or T3271C mutation derived from patients with MELAS are deficient in a normal taurine-containing modification (τm5U; 5-taurinomethyluridine) at the anticodon wobble position. To examine decoding disorder of the mutant tRMA due to the wobble modification deficiency independent of the pathogenic point mutation itself, we used a molecular surgery technique to construct an mt tRNALeu(UUR) molecule lacking the taurine modification but without the pathogenic mutation. This "operated" mt tRNALeu(UUR) without the taurine modification showed severely reduced UUG translation but no decrease in UUA translation. We thus concluded that the UUG codon-specific translational defect of the mutant mt tRNAsLeu(UUR) is the primary cause of MELAS at the molecular level. This result could explain the complex I deficiency observed clinically in MELAS.
UR - http://www.scopus.com/inward/record.url?scp=6344221310&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=6344221310&partnerID=8YFLogxK
U2 - 10.1073/pnas.0405173101
DO - 10.1073/pnas.0405173101
M3 - Article
C2 - 15477592
AN - SCOPUS:6344221310
SN - 0027-8424
VL - 101
SP - 15070
EP - 15075
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 42
ER -